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The annotated genomes of organisms define a ‘blueprint’ of their
possible gene products. Post-genome analyses attempt to confirm
and modify the annotation and impose a sense of the spatial,
temporal and developmental usage of genetic information by the
organism. Here we describe a large-scale, high-accuracy (average
deviation less than 0.02 Da at 1,000 Da) mass spectrometric
proteome analysis1–3 of selected stages of the human malaria
parasite Plasmodium falciparum. The analysis revealed 1,289
proteins of which 714 proteins were identified in asexual blood
stages, 931 in gametocytes and 645 in gametes. The last two
groups provide insights into the biology of the sexual stages of
the parasite, and include conserved, stage-specific, secreted and
membrane-associated proteins. A subset of these proteins con-
tain domains that indicate a role in cell–cell interactions, and
therefore can be evaluated as potential components of a malaria
vaccine formulation. We also report a set of peptides with
significant matches in the parasite genome but not in the protein
set predicted by computational methods.
The Plasmodium falciparum parasite is pre-committed to one of
three different developmental pathways on re-invasion of a host
erythrocyte4. Either it develops asexually, resulting in proliferation,
or it develops into a male or a female gametocyte—sexual precursor
forms that maintain a stable G1 cell cycle arrest and circulate in the
peripheral blood stream when mature. Gametocytes are activated
in the mid-gut of the mosquito when ingested by the vector
through the consumption of a blood meal, and rapidly develop
into mature gametes that fertilize to form zygotes. The zygotes
mature into a motile invasive form, the ookinete, which is
adapted for colonization of the mosquito. Clearly, sexual devel-
opment and fertilization are essential processes within the parasite
life cycle and one strategy of vaccination (transmission blocking)
seeks their interruption through antibody-based blockades.
Although good candidates for such vaccines exist, it is an accepted
view that an effective vaccine will need to target several stages of
the parasite and several components of the different forms of the
parasite5. High-throughput proteome studies on pure parasite
forms are a rapid and sensitive means to discover such vaccine
candidates.
To define the proteome of the asexual and sexual blood stages of
the malaria parasite P. falciparum (NF54 isolate), purified asexual
(trophozoites and schizonts, Fig. 1a, left panel) and sexual stage
parasites (gametocytes, right panel) or gametes (not shown) were
extracted by freeze–thawing and centrifugation, yielding soluble
and insoluble (pellet) fractions (Fig. 1b). The result of a typical
gametocyte extraction is shown in Fig. 1c, revealing that most of the
P. falciparum and red blood cell (RBC) proteins were present in the
soluble fraction, whereas membrane proteins such as the gameto-
cyte-specific cell surface protein Pfs48/45 (ref. 6) were found
exclusively in the pellet fraction, as revealed by western blotting
(Fig. 1c). These complex protein mixtures were then analysed ‘gel
free’ (differentially extracted membrane fractions) or separated
into ten molecular mass fractions by one-dimensional gel electro-
phoresis followed by excision of equally spaced bands after precisely
removing haemoglobin and globin (Fig. 1c, right panel), and tryptic
digestion. The tryptic peptides were separated by reversed phase
liquid chromatography coupled to quadrupole time-of-flight mass
spectrometry for peptide sequencing (nanoLC-MS/MS). Iterative
calibration algorithms were used to achieve a final, average absolute
mass accuracy of better than 20 parts per million (p.p.m.) in both
the precursor and fragment ions, or a mass deviation of 0.03 Da for a
typical tryptic peptide of mass 1,300 Da.
These high-accuracy spectra were searched against a combined
human and draft P. falciparum database, using probability-based
scoring in which the fragment ions are matched against the
calculated fragments of all tryptic peptides from the human and
parasite sequences7. A total of 7,548 distinct peptides from the
putative set of malaria proteins were matched with significant
probability scores (Supplementary Table A). These peptides
mapped to 1,709 malaria proteins. Additional constraints were
applied to the peptides, including peptide size, discrimination to
the next best match, and features of the tandem mass spectra such as
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the dominant amino-terminal and inhibited carboxy-terminal
fragmentation of proline. These criteria resulted in a list of 1,289
unique proteins that were identified with high confidence, compris-
ing about 23% of the current proteome prediction8 (Supplementary
Table B). Roughly one-third of the malaria proteins identified
appeared in both the soluble and insoluble fractions; the remaining
two-thirds were present either in the insoluble or in the soluble
fraction (Fig. 2a). Taken together, the analysis revealed 714 malaria
proteins in asexual stage parasite preparations, 931 in gametocytes
and 645 in gametes. The analyses also resulted in identification of
more than 1,000 human proteins.
At present, 315 malaria proteins have been found solely in
gametocytes, 226 in trophozoites and schizonts, and 97 in gametes
(Fig. 2b). A total of 575 proteins were found only in sexual stages
(gametocytes plus gametes) and 488 proteins were present in both
asexual and sexual stages. The definitive classification of a protein as
stage-specific is tentative however, and awaits full analysis of all life
cycle stages. Moreover, biological samples are rarely completely pure
or synchronous (see Methods). The well-characterized, sexual
stage-specific surface antigen, Pfs48/45, highlights this point.
Three Pfs48/45-derived peptides were detected in the asexual
preparations as opposed to 57 in gametocytes. Integration of the
peptide ion currents, a quantity roughly proportional to molar
amount of peptide species (see Supplementary Fig. A), yielded a
protein abundance ratio of more than eight between the two stages.
The unexpected presence of Pfs48/45 in asexual stages is probably
due to a small percentage of committed gametocytes in the asexual
preparations from previous cycles of growth that cannot be physi-
cally separated from asexual-stage parasites. This interpretation is
supported by western and northern blot analyses9 and was further
corroborated by quantitative polymerase chain reaction with
reverse transcription (RT–PCR) analysis (Fig. 1c and Table 1).
Notwithstanding the restrictions, the data are of sufficiently high
quality and coverage to justify the classification of a large number of
known and new proteins as ‘stage-specific’. In fact, the small
gametocyte contaminations in the asexual preparation strengthens
the stage-specific classification of those proteins that are found
exclusively in sexual stage parasites such as Pfg377, gene 11-1 and
the hypothetical protein PF14_0039. A total of 517 peptides from
the sexual stage antigen Pfg377 (ref. 10) were detected in the
gametocytes and gamete preparations whereas not a single Pfg377
peptide was detected in the asexual stage, illustrating the exquisite
sensitivity of the analytical procedure as well as the quality of the
biological sample. Collectively, mass spectrometric and quantitative
RT–PCR analysis (see below) indicates that expression of Pfg377,
gene 11-1 and the hypothetical protein PF14_0039 is turned on later
Figure 1 Differential extraction of parasite-infected red blood cells (RBCs) and flow chart
of MS analysis. a, Giemsa staining of purified trophozoites and schizonts (left panel;
asexual stage parasites), and gametocytes (right panel; sexual stage parasites).
b, Extraction procedure for infected RBCs using freeze–thaw lyses and centrifugation,
yielding a soluble and insoluble (pellet) fraction. c, The soluble and insoluble fraction from
5 £ 105 gametocytes were separated on a 10% SDS gel and stained with Coomassie blue
(left panel) or processed for western blotting and developed with a rabbit polyclonal
antibody to Pfs48/45. The arrowhead indicates Pfs48/45. The right hand panel shows the
insoluble fraction of 2 £ 107 gametocytes. d, Mass spectrometric analysis of one of the
gel slices shown in c. The top panel shows the summed ion current of all peptides eluting
at a particular time. The middle panel shows a typical mass spectrum obtained from the
eluting peptides. The bottom panel shows a fragmentation spectrum of the peptide with a
mass of 515.82 indicated in the middle panel and magnification (inset) of one of the
fragments. Database searching with this fragmentation information results in
identification of peptide LFGIVGSIPK from Pfs48/45.
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during gametogenesis than Pfs48/45.
Among the identified asexual proteins described previously are
stage-specific antigens KAHRP, PfEMP3, PfSAR1 and PfSBP1,
which are involved in the assembly of structures specific to the
blood stage, such as knobs11. Schizont-specific proteins associated
with the merozoite surface and invasive organelles such as MSP1, -2,
-3, -6, -7 and -7a, or AMA1 and rhoptry-associated proteins RAP1,
RAP2 and Rhop1 (for review of the proteins involved, see ref. 12)
were also readily detected. Additionally, numerous hypothetical
proteins containing a predicted signal sequence (61) and/or a
transmembrane domain (189) were discovered, thus extending
the repertoire of confirmed gene products and of potential new
vaccine candidates (Supplementary Table B). Our analysis did not
reveal any high-scoring peptides in the asexual blood stage prepa-
rations that could be assigned unambiguously to a member of the
highly variable surface molecules of the PfEMP1 family, which are
Table 1 Quantification of stage-specific proteins
Protein name Accession no. RT–PCR* MS-XIC†
...................................................................................................................................................................................................................................................................................................................................................................
Asexual stage-specific proteins (known)
Apical membrane antigen 1 (AMA1) PF11_0344 3 (1) .2
Cyto-adherence-linked asexual protein (CLAG9) PFI1730w 13 (3) .5
Mature parasite-infected erythrocyte surface antigen (MESA) PFE0040c 7 (4) .12‡
Merozoite surface protein 1 (MSP1) PFI1475w 66 (37) .60
Cysteine protease PFB0340c 221 (61) .8
Sexual stage-specific proteins (known)
Actin II PF14_0124 26 (4) .10
Pfs16 surface antigen PF11_0318 8 (2) .6
Sexual stage-specific surface antigen (Pfs48/45) PF13_0247 43 (19) 8.2 (4.0)‡
Transmission-blocking target antigen (Pfs230) PFB0405w 61 (20) .6
Plasmodium falciparum gametocyte antigen (Pfg377) PFL2405c 289 (79) .20
Gene 11-1 PF10_0374 160 (14) .8
Sexual stage antigen Pfs25 PF10_0303 858 (290) .4
Sexual stage-specific proteins (novel)
Hypothetical protein PF14_0039 597 (208) .17
Hypothetical protein PF11_0310 9 (5) .2
Hypothetical protein PF11_0413 5 (1) 2.4 (0.5)
...................................................................................................................................................................................................................................................................................................................................................................
*Ratio between stages. RT–PCR normalized to heat shock protein 86, HSP86. Standard deviations are indicated in parentheses.
†Ratio between stages. Values were calculated from ion currents for the precise peptide molecular mass using maximum peak heights of peptides with more than 30 ion counts.
‡Extracted ion chromatogram (XIC) of the peptides of these proteins are presented in Supplementary Fig. A.
Figure 2 Schematic representation of proteomic data. a, Compilation of unique and
common proteins in the soluble and insoluble fractions. Bars represent the number of
proteins in the different preparations (trophozoites/schizonts, gametocytes and gametes)
that were assigned to malaria or human RBCs. Proteins present solely in soluble (open
bars) or insoluble (black bars) fractions as well as protein common to both fractions
(shaded bars) are indicated. b, Venn diagram of the distribution of identified malaria
proteins over the three blood stages. The distribution between trophozoites plus schizonts,
gametocytes and gametes is shown.
Figure 3 LCCL/lectin domain proteins expressed in sexual stages of P. falciparum. The
SMART22-generated graphic descriptions of the five proteins expressed in sexual stages
that contain LCCL/lectin domains are shown. The P. falciparum homologue of PSLAP16
(GenBank accession number AAL58521), PF14_0067, contains a signal sequence
(cleavage: amino acids, aa, 22 and 23); 3 LCCL domains (position: aa, 275–362, E value
1.28 £ 1023; 670–676, E value 8.11 £ 1025; and 1169–1255, E value
6.89 £ 10216); 2 scavenger receptor (SR) domains (aa 401–515, E value 3.41 £ 1026
and 528–642, E value 3.10 £ 1027); 1 lipoxygenase homology 2 (LH2) domain (aa 157–
265, E value 8.20 £ 1023); and one SCOP ConA lectin-like domain (aa 911–1013, E
value 1 £ 1024). PF14_0723 contains a signal peptide (cleavage: aa 19 and 20); 1 LCCL
domain (aa 752–843, E value 1.4 £ 10221); and a PFAM predicted discoidin domain (aa
296–420, E value 8.7 £ 1022). PFA0445w contains a predicted signal sequence
(cleavage: aa 24 and 25); 1 LCCL domain (aa 740–827, E value 4.49 £ 1026); 1 SCOP
kringle family domain (aa 43–95, E value 1.61 £ 1022; not shown); and 1 SCOP dld7pm
galactose-binding motif (aa 593–714, E value 4.01 £ 1023). PF14_0532, also
recognized as a gametocyte-specific transcript in P. berghei (AF491294), contains signal
sequence (cleavage: aa 23 and 24); 1 LCCL domain (aa 724–815, E value 8.87 £ 1024);
and 1 PFAM ricin domain (aa 222–269, E value 4.0 £ 1022). PF14_0491 is not
predicted to contain a signal sequence but contains a SCOP dlacc anthrax protective
antigen family with an immunoglobulin fold (aa 204–372, E value 3 £ 1029) and SCOP/
FN2 kringle-like (aa 30–80, E value 6.7 £ 1022; not shown).
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knob-associated and primarily responsible for cyto-adherence of
parasites to the peripheral vascular endothelium. PfEMP1 may be
expressed at very low abundance in P. falciparum strain NF54, or
poorly extracted by our methods. Our mass spectrometry analyses
revealed almost all of the known proteins specific to P. falciparum
gametocytes and gametes (Supplementary Table B). For example,
four of the six members of the P48/45 family that are transcribed
in sexual stages were readily identified. In addition we detected
the sexual stage-specific Pfs48/45 paralogue, Pf47, for the first
time.
To corroborate and extend the stage specificity, we compared not
only the absence or presence of particular peptides in the respective
fractions, but also integrated the ion currents of peptides (see
Supplementary Fig. A). This is important because it is possible
that a peptide is not selected for sequencing owing to the complexity
of the sample, but is nevertheless present at significant amounts. For
example, MESA was found with 18 peptides in the asexual stage. The
ion currents at the corresponding elution times in the preparation
of a sexual stage were inspected but did not show any signal at the
respective peptide masses. Similarly, analysis of peptide ion currents
corresponding to hypothetical proteins such as PF14_0039 revealed
a protein abundance ratio of at least 17:1 between the sexual and
asexual stages. We next performed quantitative RT–PCR using
messenger RNA from parallel asexual, gametocyte and gamete
parasite preparations and gene-specific primer sets for a group of
hypothetical and known proteins and an arbitrary selection of
putative sexual and asexual stage-specific proteins. RT–PCR
ratios of signals obtained in asexual versus sexual parasites
ranged from 3-fold to over 850-fold (Table 1). In accord with
the mass spectrometric findings, mRNA from Pfg377, gene 11-1
and the protein PF14_0039, but not Pfs48/45, were detected
exclusively in gametocyte and gamete preparations. Comparison
between the results obtained with mass spectrometry and quantitat-
ive RT–PCR shows that the changes observed in protein abundance
between the asexual and sexual stages were also reflected in their
mRNA levels.
Erythrocytic stages of the parasites are under enhanced oxidative
stress and are particularly vulnerable to exogenous challenges by
reactive oxygen species. Therefore it is interesting to note that
proteins involved in protection against oxidative stress—the glyox-
alase enzymatic system associated with glutathione—seem to be
upregulated in gametes and gametocytes, such as glyoxalases I
(PF11_0145) and II (PFL0285w), and two different glutaredoxins
(MAL6P1.72 and PFC0271c)13. Some of the enzymes involved in the
synthesis and metabolism of glutathione such as glutathione S-
transferase (PF14_0187) and g-glutamylcysteine synthetase
(PFI0925w) are exclusively present in sexual stages. Others were
found in sexual as well as asexual stages; these include glutathione
peroxidase (PFL0595c) and glutathione reductase (PF14_0192).
Furthermore, thioredoxin systems are also readily found in sexual
stages (thioredoxin, PF14_0545 and PF13_0272 (secreted); thior-
edoxin peroxidase, PFL0725w; and thioredoxin reductase,
PFL0725w).
Another stage-specific feature is the motility of male gametes.
This involves the axoneme, a specialized structure consisting of two
parallel microtubules thought to be connected by dynein com-
plexes, which so far have only been demonstrated in mature
merozoites14. The full P. falciparum genome reveals 12 genes that
are expected to encode different dynein forms. They are conserved
throughout Plasmodium species and have maximum homology to
flagellar dyneins (for example, PF11_0240). Our analysis indicates
that at least six of these (three light and three heavy chains) are
expressed exclusively in sexual stages. Further specialized motility-
associated proteins that may assist in the formation of the axoneme,
such as actin II, a-tubulin II, b-tubulin, putative kinesins, as well as
predicted tubulin-specific chaperones, are also evident.
The male gamete has been shown to bind to sialic acid on
erythrocytes through a lectin-like activity15. Therefore, one antici-
pated finding within the proteome of the sexual stage was the
presence of proteins (protein families) that exhibit appropriate
adhesion properties. Our analysis revealed five proteins expressing
predicted lectin domains of which four contain an additional LCCL
motif thought to be involved in protein–protein interactions—all
five are expressed exclusively in sexual stages (Fig. 3). One of these
proteins, PSLAP (PF14_0067; AAL58521), has been characterized
previously as gametocyte-specific and has been shown to contain
multiple different domains suggestive of a role in cell–cell inter-
actions16. A second (PF14_0723) has been characterized as a
gametocyte-specific transcript in the rodent parasite Plasmodium
berghei (GenBank accession number AF491294). Four of the five are
predicted to be secreted proteins (PF14_0723, PFA0445w,
PF14_0532, PSLAP). A fifth protein (PF14_0491) contains only a
lectin domain and is predicted to be non-secreted; however, we
believe that this is due to annotation based on a short exon-splice
model, because alternative models would create a signal peptide.
Interrogation of the Plasmodium genomes (P. falciparum and P. y.
yoelii) suggests that these proteins are conserved in both models
Figure 4 Refinement of gene structure and re-annotation using proteomic data.
a, (G  C) plot in an ARTEMIS window corresponding to the genomic region of the gene
PF11_0169 on chromosome 11 of P. falciparum. b, Alternative gene models for
PF11_0169. The green and yellow gene models represent the original and refined gene
structure of PF11_0169, respectively. The red blocks represent the peptide
LQIPSLNIIQVR and its occurrence in respect to the green and the yellow gene models.
c, d, Sections from an ARTEMIS window showing the splice-donor site of exon I and the
splice-acceptor site of exon II of the yellow gene model. The three-frame translation is
shown with hash or asterisk, denoting stop codons. The red blocks together represent the
full-length peptide LQIPSLNIIQVR. e, Tandem mass spectrum of the orphan peptide
LQIPSLNIIQVR. C-terminal fragment ions (Y ions) are indicated as well as a partial
sequence.
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and in other Plasmodium species that infect humans, and that
expression of LCCL-domain-containing proteins is restricted to
the parasite stages found in the mid-gut of the mosquito. Future
investigations will determine the precise role of these proteins in
the complexity of gamete fertilization, erythrocyte binding by
male gametes, interactions with the host and vector immune
systems, and the surface carbohydrate structures of the mosquito
mid-gut.
The gel slice approach chosen for proteome analysis allowed us to
correlate apparent molecular masses with gene annotation derived
from theoretical mass predictions, revealing outliers that may be
due to protein processing or to incomplete gene annotation. Protein
Pfg377, for example, probably represents a case of protein
processing (Supplementary Fig. B). The C-terminal portion of
Pfg377 was covered with 69 sequenced peptides solely in the
protein mixture from gel slice 5 (relative molecular mass (M r)
range of 100,000 to 140,000 (100K–140K)), whereas 15 peptides
matching the N-terminal portion were found exclusively in gel 7
(65K–84K). Northern blot analysis10 and quantitative RT–PCR
using 5
0
and 3
0
specific primer sets (data not shown) indicate that
the proteins are encoded by a single gene that is processed after
translation.
The parasite genome is highly (A  T)-rich and has proven
difficult to assemble and annotate8. For this reason, we also
performed direct genome searches17 where the malaria genome
rather than the predicted set of proteins was searched by the mass
spectrometric data. A large number of additional hits emerged.
After analysing these ‘orphan’ peptide hits in the genome of
P. falciparum, we were able to identify additional exons or assign
different exon–intron boundaries of previously annotated genes
using the ARTEMIS annotation tool18. One such orphan peptide,
LQIPSLNIIQVR, identified two additional exons of the gene
PF11_0169 on chromosome 11, annotated as a hypothetical pro-
tein. With this information we were able to identify two further
exons and modify the gene structure appropriately. This led to re-
annotation of the previously annotated hypothetical protein
PF11_0169 as a putative homologue of sno-type pyridoxin biosyn-
thesis protein (Fig. 4). The orphan peptide not only identified the
two exons of the gene PF11_0169 but also verified the boundaries of
the intron between the exons I and II. With the refined gene model
we were able to re-annotate the gene with appropriate Gene
Ontology (GO) terms. Initial analysis similar to the one outlined
above led to eight definite and six probable gene annotation
changes. Supplementary Table C lists more than 100 high-quality
orphan peptides that can be used in gene annotation and the finding
of new genes.
We have applied state-of-the-art proteomics techniques to obtain
valuable information about stage-specific expression and localiz-
ation of malaria proteins as well as information useful in confirming
and extending the bioinformatics analysis of the proteome. Further
work could encompass additional stages of the parasite life cycle and
make use of the rapidly evolving mass spectrometric technology,
associated bioinformatics, as well as direct comparison of stages
using stable isotope techniques. A
Methods
Preparation of parasites
Plasmodium falciparum parasites were cultured using a semi-automated culture system.
Asexual stages (trophozoites and schizonts) were purified using the Variomacs system
essentially as described14. For the production of gametocytes, parasites were cultured for
14 days without addition of red blood cells. The gametocyte cultures were treated with
50 mM N-acetyl-glucosamine from day 8 to 12 after the start of the culture to remove
asexual stage parasites. After a total of 14 days culture the gametocytes were collected and
purified using the Variomacs system as described14. For the production of gametes,
purified gametocytes were pelleted and incubated in Gm buffer containing 100 mM
xanthurenic acid for a period of 3 h at 21 8C (ref. 19). (Gm buffer contains 1.67 mg ml
21
glucose, 8 mg ml21 NaCl, 1 mg ml21 Tris, pH 8.1.) Every effort was made to minimize
enzymatic activity and protein degradation during sampling and the subsequent isolation
of the parasites. However, we cannot exclude that some of the differences in protein
profiles that we observe between the different life-cycle stages may be a consequence of the
sample-handling procedures.
Sample preparation
The infected red blood cells (107 cells) of each stage were divided into a soluble and
insoluble fraction by freeze–thawing several times and pelleted by centrifugation at
13,000 r.p.m. (16,100 g). Proteins were extracted in SDS–polyacrylamide gel
electrophoresis (PAGE) loading buffer and separated into ten fractions on a 10% protein
gel. The separated proteins were treated with dithiothreitol (DTT) and iodoacetamide,
and in-gel digested with trypsin20. Proteins were also extracted by 8 M urea, 100 mM Tris-
HCl, pH 8.0, treated with DTT and iodoacetamide, and digested in-solution with
endoprotease Lys-C and trypsin after dilution to 2 M urea. Proteins from the insoluble
fractions were further extracted with 1% deoxycholic acid (DOC), 100 mM Tris-HCl, pH
8.0, and digested together with the remaining pellet as above in the presence of 0.05%
DOC.
NanoLC-MS/MS analysis of malaria proteins
Peptide mixtures were loaded onto 75-mm ID columns packed with 3-mm C18 particles
(Vydac) and eluted into a quadruple time-of-flight mass spectrometer (QSTAR, Sciex-
Applied Biosystems). Fragment ion spectra were recorded using information-dependent
acquisition and duty-cycle enhancement (see ref. 21 and references therein for a more
detailed description of the method). The three malaria stages studied were analysed at least
in duplicate. In total, more than 100 nanoLC-MS/MS runs were analysed, yielding more
than 200,000 peptide-sequencing events.
Data analysis
Peak lists containing the precursor masses and the corresponding MS/MS fragment masses
were generated from the original data file and searched in the annotated P. falciparum
database (Sanger/TIGR) combined with the human IPI database (European
Bioinformatics Institute) using the Mascot program (Matrix Science). Identified peptides
that were not unique or had a score less than 20 were removed. Proteins identified with a
combined peptide score of higher than 60 were considered significant, and lower scoring
proteins were manually verified or rejected. Iterative calibration algorithms on the basis of
identified peptides were used to achieve a final average absolute mass accuracy of better
than 20 p.p.m. in both the precursor and fragment ions. Relative protein abundance
between the malaria stages was based on the total number of unique peptides identified for
each protein and was further supported by extracted ion chromatograms (XIC) for
individual peptides within an elution time window of 3 min (see also Supplementary
Fig. A).
Quantitative real-time RT–PCR
Relative mRNA abundance was quantified by real-time PCR with the GeneAmp 5700
Sequence Detection System (Applied Biosystems) using the SYBR Green PCR Master Mix
kit (Applied Biosystems). Total RNA was isolated from two stages: asexual blood stage
(trophozoites and schizonts) and the sexual blood stage (gametocytes), both prepared as
described above. RNA was isolated from 4 £ 107 parasites using TRIzol reagent (Gibco
BRL). A total of 2 mg of RNA was used for complementary DNA synthesis. RNA was treated
with DNaseI (Pharmacia) after which cDNA was synthesized with random hexamers
and Superscript II enzyme (Gibco BRL), according to standard protocols. cDNA was
dissolved in 50 ml diethyl pyrocarbonate (DEPC)-treated H2O. A total of 3 ml of £ 10
and £ 100 diluted cDNA was used for real-time PCR. Primers were designed by Primer
Express software (Applied Biosystems). The mRNA levels for each gene were normalized
against heat shock protein 86. For each gene the relative mRNA abundance was
determined by calculating the ratio of asexual:gametocyte stage and gametocyte:asexual
stage.
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